Alpine Associates Management’s RayzeBio RYZB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-762,900
Closed -$47.4M – 53
2023
Q4
$47.4M Buy
+762,900
New +$19M 2.43% 15

Alpine Associates Management's RYZB Position: Q1 2024 in Review

Alpine Associates Management sold out of RayzeBio (RYZB) in Q1 2024, closing a stake of 762,900 shares — an estimated $47.4M sold.

Alpine Associates Management first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $47.4M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

  • Alpine Associates Management reported no remaining RayzeBio position as of Q1 2024 after selling out during the quarter.
  • Alpine Associates Management sold 762,900 RayzeBio shares in Q1 2024, an estimated $47.4M.
  • Alpine Associates Management first reported a position in RayzeBio in Q4 2023 and held it in 1 quarter.
  • Alpine Associates Management's RayzeBio position peaked at $47.4M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held RayzeBio as of Q1 2024.

Based on Alpine Associates Management's 13F filing for Q1 2024, filed 9 May 2024.